Share
Core Japanese inflation accelerated in March, yet BoJ likely to stand pat
Chief International Economist
Tariffs won't bring the manufacturing of generic pharmaceuticals back to the US, but there are alternatives
Key data from South Korea and Tokyo, while China seen leaving rates unchanged
By Inga Fechner and Thijs Geijer